VYNE Therapeutics Inc.

Contributing Author

Recent Articles by VYNE Therapeutics Inc.

Jul-23	VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience GlobeNewswire
Jul-21	VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience GlobeNewswire
Jul-10	VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience GlobeNewswire
Dec-17	VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement GlobeNewswire
Nov-06	VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update GlobeNewswire
Aug-14	VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update GlobeNewswire
Jul-30	VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo GlobeNewswire
Jul-02	VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202 GlobeNewswire
May-08	VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update GlobeNewswire